Science Secures $230 Million for Brain Implant Development

Neurotechnology company Science has successfully raised $230 million from investors to advance the commercialization of its implant designed to address blindness. Bloomberg posted on X, highlighting the company's plans to further develop sophisticated brain devices. This funding round marks a significant step for Science as it aims to bring innovative solutions to the market, potentially transforming the landscape of neurotechnology. The investment will support the company's efforts in enhancing its current technologies and exploring new avenues in brain device development.